Prevalence of High Plasmatic 3OMethyldopa Level in a Specific Population of Patients With a Symptomatology Compatible With AADC Deficiency
Clinical trial NCT05211609 · UNKNOWN
Trial details
- NCT number
- NCT05211609
- Sponsor
- University Hospital, Montpellier
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-20
- Primary completion
- 2024-05-01
- Enrollment
- 388
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.